{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:18:08Z","timestamp":1782940688896,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA028215"],"award-info":[{"award-number":["R01AA028215"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA028145"],"award-info":[{"award-number":["R01AA028145"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA028800"],"award-info":[{"award-number":["R21AA028800"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA025547"],"award-info":[{"award-number":["R21AA025547"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brackenridge Fellowship","award":["Brackenridge Fellowship"],"award-info":[{"award-number":["Brackenridge Fellowship"]}]},{"DOI":"10.13039\/100001083","name":"DSF Charitable Foundation","doi-asserted-by":"publisher","award":["DSF Charitable Foundation"],"award-info":[{"award-number":["DSF Charitable Foundation"]}],"id":[{"id":"10.13039\/100001083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P50DA046346"],"award-info":[{"award-number":["P50DA046346"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00213-025-06782-2","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:58:02Z","timestamp":1744124282000},"page":"2035-2045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sex specific effects of ketamine, but not other glutamate receptor modulators, on ethanol self-administration and reinstatement of ethanol seeking in rats"],"prefix":"10.1007","volume":"242","author":[{"given":"Megan L.","family":"Bertholomey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camryn","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan D.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2083-0231","authenticated-orcid":false,"given":"Mary M.","family":"Torregrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"6782_CR1","doi-asserted-by":"publisher","first-page":"160175","DOI":"10.1503\/jpn.160175","volume":"42","author":"LR Aleksandrova","year":"2017","unstructured":"Aleksandrova LR, Phillips AG, Wang YT (2017a) Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. J Psychiatry Neurosci 42:160175","journal-title":"J Psychiatry Neurosci"},{"key":"6782_CR2","doi-asserted-by":"publisher","first-page":"160175","DOI":"10.1503\/jpn.160175","volume":"42","author":"LR Aleksandrova","year":"2017","unstructured":"Aleksandrova LR, Phillips AG, Wang YT (2017b) Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. J Psychiatry Neurosci 42:160175","journal-title":"J Psychiatry Neurosci"},{"key":"6782_CR3","unstructured":"Ardinger C, Winkler G, Lapish C, Winkler G et al CC Lapish, NJ GrahameAlcohol, 2021\u2022Elsevier"},{"key":"6782_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s00213-016-4278-x","volume":"233","author":"ML Bertholomey","year":"2016","unstructured":"Bertholomey ML, Nagarajan V, Torregrossa MM (2016) Sex differences in reinstatement of alcohol seeking in response to cues and Yohimbine in rats with and without a history of adolescent corticosterone exposure. Psychopharmacology 233:2277\u20132287. https:\/\/doi.org\/10.1007\/s00213-016-4278-x","journal-title":"Psychopharmacology"},{"key":"6782_CR4","doi-asserted-by":"publisher","unstructured":"Bertholomey ML, Nagarajan V, Smith DM, Torregrossa MM (2022) Sex- and age-dependent effects of chronic corticosterone exposure on depressive-like, anxiety-like, and fear-related behavior: role of amygdala glutamate receptors in the rat. Front Behav Neurosci 16. https:\/\/doi.org\/10.3389\/FNBEH.2022.950000","DOI":"10.3389\/FNBEH.2022.950000"},{"key":"6782_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/J.CPR.2005.11.005","volume":"26","author":"CM Bradizza","year":"2006","unstructured":"Bradizza CM, Stasiewicz PR, Paas ND (2006) Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin Psychol Rev 26:162\u2013178. https:\/\/doi.org\/10.1016\/J.CPR.2005.11.005","journal-title":"Clin Psychol Rev"},{"key":"6782_CR7","doi-asserted-by":"publisher","unstructured":"Browne CA, Lucki I (2013) Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 4. https:\/\/doi.org\/10.3389\/FPHAR.2013.00161","DOI":"10.3389\/FPHAR.2013.00161"},{"key":"6782_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","volume":"70","author":"N Carrier","year":"2013","unstructured":"Carrier N, Kabbaj M (2013) Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70:27\u201334. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.12.009","journal-title":"Neuropharmacology"},{"key":"6782_CR9","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/S00213-021-05825-8","volume":"238","author":"AA Conley","year":"2021","unstructured":"Conley AA, Norwood AEQ, Hatvany TC et al (2021) Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis. Psychopharmacology 238:1737\u20131752. https:\/\/doi.org\/10.1007\/S00213-021-05825-8","journal-title":"Psychopharmacology"},{"key":"6782_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4088\/JCP.v67n0211","volume":"67","author":"KP Conway","year":"2006","unstructured":"Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 67:247\u2013257","journal-title":"J Clin Psychiatry"},{"key":"6782_CR11","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1523\/JNEUROSCI.4883-05.2006","volume":"26","author":"C Creeley","year":"2006","unstructured":"Creeley C, Wozniak DF, Labruyere J et al (2006) Low doses of memantine disrupt memory in adult rats. J Neurosci 26:3923\u20133932. https:\/\/doi.org\/10.1523\/JNEUROSCI.4883-05.2006","journal-title":"J Neurosci"},{"key":"6782_CR12","unstructured":"Crowley N, Magee S, Feng M, Magee SN, Feng M, Jefferson SJ, Morris CJ, Dao NC, Brockway DF et al B LuscherNeuropharmacology, 2019\u2022Elsevier"},{"key":"6782_CR13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2165\/00023210-200317150-00005","volume":"17","author":"GA Fava","year":"2003","unstructured":"Fava GA, Ruini C, Sonino N (2003) Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs 17:1109\u20131117. https:\/\/doi.org\/10.2165\/00023210-200317150-00005","journal-title":"CNS Drugs"},{"key":"6782_CR99","doi-asserted-by":"crossref","unstructured":"Franceschelli, A., Sens, J., Herchick, S., Thelen, C., & Pitychoutis, P. M. (2015). Sex differences in the rapid and the sustainedantidepressant-like effects of ketamine in stress-na\u00efve and \u201cdepressed\u201d mice exposed to chronic mild stress. Neuroscience, 290, 49-60.","DOI":"10.1016\/j.neuroscience.2015.01.008"},{"key":"6782_CR14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1172\/JCI130808","volume":"130","author":"DM Gerhard","year":"2020","unstructured":"Gerhard DM, Pothula S, Liu RJ et al (2020) GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions. J Clin Invest 130:1336\u20131349. https:\/\/doi.org\/10.1172\/JCI130808","journal-title":"J Clin Invest"},{"key":"6782_CR15","doi-asserted-by":"publisher","unstructured":"Guiraud J, Spanagel R, van den Brink W (2024) Substitution therapy for patients with alcohol dependence: mechanisms of action and efficacy. 175:187\u2013239. https:\/\/doi.org\/10.1016\/BS.IRN.2024.03.005","DOI":"10.1016\/BS.IRN.2024.03.005"},{"key":"6782_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R","volume":"27","author":"WA Hunt","year":"1971","unstructured":"Hunt WA, Barnett LW, Branch LG (1971) RELAPSE RATES IN ADDICTION PROGRAMS. J Clin Psychol 27:455\u2013456","journal-title":"J Clin Psychol"},{"key":"6782_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/J.NEUROPHARM.2018.01.017","volume":"142","author":"I Ivan Ezquerra-Romano","year":"2018","unstructured":"Ivan Ezquerra-Romano I, Lawn W, Krupitsky E, Morgan CJA (2018) Ketamine for the treatment of addiction: evidence and potential mechanisms. Neuropharmacology 142:72\u201382. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2018.01.017","journal-title":"Neuropharmacology"},{"key":"6782_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/J.COPH.2014.11.006","volume":"20","author":"JW Johnson","year":"2015","unstructured":"Johnson JW, Glasgow NG, Povysheva NV (2015) Recent insights into the mode of action of memantine and ketamine. Curr Opin Pharmacol 20:54\u201363. https:\/\/doi.org\/10.1016\/J.COPH.2014.11.006","journal-title":"Curr Opin Pharmacol"},{"key":"6782_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.35946\/ARCR.V40.1.01","volume":"40","author":"R Kathryn Mchugh","year":"2019","unstructured":"Kathryn Mchugh R, Weiss RD (2019) Alcohol use disorder and depressive disorders. Alcohol Res 40:e1\u2013e8. https:\/\/doi.org\/10.35946\/ARCR.V40.1.01","journal-title":"Alcohol Res"},{"key":"6782_CR20","doi-asserted-by":"publisher","unstructured":"Kelson M, Burnett JM, Matthews A, Juneja T (2023) Ketamine treatment for alcohol use disorder: A systematic review. Cureus 15. https:\/\/doi.org\/10.7759\/CUREUS.38498","DOI":"10.7759\/CUREUS.38498"},{"key":"6782_CR21","doi-asserted-by":"publisher","unstructured":"McIntyre RS, Jain R (2024) Glutamatergic modulators for major depression from theory to clinical use. https:\/\/doi.org\/10.1007\/S40263-024-01114-Y. CNS Drugs","DOI":"10.1007\/S40263-024-01114-Y"},{"key":"6782_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3121\/CMR.4.3.163","volume":"4","author":"RH Moos","year":"2006","unstructured":"Moos RH, Moos BS, Timko C (2006) Gender, treatment and self-help in remission from alcohol use disorders. Clin Med Res 4:163\u2013174. https:\/\/doi.org\/10.3121\/CMR.4.3.163","journal-title":"Clin Med Res"},{"key":"6782_CR23","doi-asserted-by":"publisher","unstructured":"Patwell R, Yang H, Pandey SC, Glover EJ (2021) An operant ethanol self-administration paradigm that discriminates between appetitive and consummatory behaviors reveals distinct behavioral phenotypes in commonly used rat strains. Neuropharmacology 201. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2021.108836","DOI":"10.1016\/J.NEUROPHARM.2021.108836"},{"key":"6782_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/J.BIOPSYCH.2004.07.016","volume":"56","author":"HM Pettinati","year":"2004","unstructured":"Pettinati HM (2004) Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry 56:785\u2013792. https:\/\/doi.org\/10.1016\/J.BIOPSYCH.2004.07.016","journal-title":"Biol Psychiatry"},{"key":"6782_CR25","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1038\/S41380-020-0796-3","volume":"26","author":"S Pothula","year":"2021","unstructured":"Pothula S, Kato T, Liu RJ et al (2021) Cell-type specific modulation of NMDA receptors triggers antidepressant actions. Mol Psychiatry 26:5097\u20135111. https:\/\/doi.org\/10.1038\/S41380-020-0796-3","journal-title":"Mol Psychiatry"},{"key":"6782_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4303\/JDAR\/236030","volume":"6","author":"AH Rezvani","year":"2017","unstructured":"Rezvani AH, Levin ED, Cauley M et al (2017) Ketamine differentially attenuates alcohol intake in male versus female alcohol preferring (P) rats. J Drug Alcohol Res 6:1\u20136. https:\/\/doi.org\/10.4303\/JDAR\/236030","journal-title":"J Drug Alcohol Res"},{"key":"6782_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/J.NEULET.2017.12.055","volume":"666","author":"J Ruda-Kucerova","year":"2018","unstructured":"Ruda-Kucerova J, Babinska Z, Luptak M et al (2018) Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats. Neurosci Lett 666:175. https:\/\/doi.org\/10.1016\/J.NEULET.2017.12.055","journal-title":"Neurosci Lett"},{"key":"6782_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbr.2013.02.030","volume":"247","author":"V Sabino","year":"2013","unstructured":"Sabino V, Narayan AR, Zeric T et al (2013a) mTOR activation is required for the anti-alcohol effect of ketamine, but not Memantine, in alcohol-preferring rats. Behav Brain Res 247:9\u201316. https:\/\/doi.org\/10.1016\/j.bbr.2013.02.030","journal-title":"Behav Brain Res"},{"key":"6782_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbr.2013.02.030","volume":"247","author":"V Sabino","year":"2013","unstructured":"Sabino V, Narayan AR, Zeric T et al (2013b) mTOR activation is required for the anti-alcohol effect of ketamine, but not Memantine, in alcohol-preferring rats. Behav Brain Res 247:9\u201316. https:\/\/doi.org\/10.1016\/j.bbr.2013.02.030","journal-title":"Behav Brain Res"},{"key":"6782_CR30","doi-asserted-by":"publisher","unstructured":"Strong CE, Wright KN, Kabbaj M (2019) Sex and individual differences in alcohol intake are associated with differences in ketamine Self-Administration behaviors and nucleus accumbens dendritic spine density. https:\/\/doi.org\/10.1523\/ENEURO.0221-19.2019. eNeuro 6:","DOI":"10.1523\/ENEURO.0221-19.2019"},{"key":"6782_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.DRUGALCDEP.2004.09.004","volume":"78","author":"M Torrens","year":"2005","unstructured":"Torrens M, Fonseca F, Mateu G, Farr\u00e9 M (2005) Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend 78:1\u201322. https:\/\/doi.org\/10.1016\/J.DRUGALCDEP.2004.09.004","journal-title":"Drug Alcohol Depend"},{"key":"6782_CR32","doi-asserted-by":"crossref","unstructured":"Worrell S, Reviews TG- 2021 Undefined therapeutic potential of ketamine for alcohol use disorder. ElsevierSD Worrell, TJ GouldNeuroscience & Biobehavioral Reviews, 2021\u2022Elsevier","DOI":"10.1016\/j.neubiorev.2021.05.006"},{"key":"6782_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ et al (2016a) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481\u2013486. https:\/\/doi.org\/10.1038\/nature17998","journal-title":"Nature"},{"key":"6782_CR34","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ et al (2016b) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481\u2013486. https:\/\/doi.org\/10.1038\/nature17998","journal-title":"Nature"},{"key":"6782_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/ARCHPSYC.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ et al (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864. https:\/\/doi.org\/10.1001\/ARCHPSYC.63.8.856","journal-title":"Arch Gen Psychiatry"},{"key":"6782_CR36","doi-asserted-by":"publisher","unstructured":"Zhou L, Duan J (2024) The role of NMDARs in the anesthetic and antidepressant effects of ketamine. CNS Neurosci Ther 30. https:\/\/doi.org\/10.1111\/CNS.14464","DOI":"10.1111\/CNS.14464"},{"key":"6782_CR37","doi-asserted-by":"publisher","unstructured":"Zolghadriha A, Anjomshoaa A, Jamshidi MR, Taherkhani F (2024) Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial. BMC Psychiatry 24. https:\/\/doi.org\/10.1186\/S12888-024-05716-0","DOI":"10.1186\/S12888-024-05716-0"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06782-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:43:12Z","timestamp":1757155392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06782-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["6782"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06782-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the policies set forth by University of Pittsburgh Institutional Animal Care and Use Committee and the National Institutes of Health Guidelines on the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}